论文部分内容阅读
目的:探讨呼吸内科对于重症哮喘的临床诊治效果。方法:选取60例患有重症哮喘的患者并平均分为对照组与研究组各30例,对照组采用氨茶碱对重症哮喘患者进行治疗,研究组在对照组的基础上结合雾化吸入糖皮质激素的方式对重症哮喘患者进行治疗,对两组患者的临床疗效进行对照比较。结果:研究组总有效率达到了96.67%,对照组总有效率则为60%,两组患者之间差异具有统计学意义(P<0.05)。结论:氨茶碱结合雾化吸入糖皮质激素的方法对重症哮喘的患者进行治疗,临床效果显著,具有安全性高、患者痛苦少、住院时间短等优势,具有临床应用及推广的价值。
Objective: To investigate the clinical diagnosis and treatment of severe asthma in respiratory medicine. Methods: Sixty patients with severe asthma were selected and equally divided into control group and study group, 30 cases in each group. The control group was treated with aminophylline for severe asthma patients. In the control group, the study group was treated with atomized inhalation of sugar Corticosteroids in patients with severe asthma treatment, the clinical efficacy of two groups of patients were compared. Results: The total effective rate reached 96.67% in the study group and 60% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: The combination of aminophylline and inhalation of glucocorticoid inhaled asthma in patients with severe asthma treatment, the clinical effect is significant, with high safety, less pain, shorter hospital stay and other advantages, with clinical application and promotion of value.